• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP53 突变在多克隆播种的结直肠癌肝转移中富集。

TP53 mutation is enriched in colorectal cancer liver metastasis in the context of polyclonal seeding.

机构信息

Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310058, China; Institut Curie, PSL Research University, Inserm, CNRS, Paris 75005, France.

Department of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing 21198, China.

出版信息

Pathol Res Pract. 2022 Aug;236:153958. doi: 10.1016/j.prp.2022.153958. Epub 2022 May 27.

DOI:10.1016/j.prp.2022.153958
PMID:35679752
Abstract

Cancer metastasis accounts for the majority of cancer motility burden. For colorectal cancer (CRC), the liver is the most common site of distant metastasis. It is still little known that cancer genomic mutations, which are a cell-intrinsic and heritable property, are enriched in CRC liver metastasis. Here, we try to answer the question in the context of polyclonal seeding. In this study, we sequenced 18 pairs of colorectal cancer primary tumors and their matched liver metastasis samples. Together with public available sequencing data, we compared the mutations in 113 primary and metastasis pairs. The TP53 mutation variant allele frequency (VAF) was significantly increased in metastasis compared to the paired primary tumor, although most of the frequently observed mutations in liver metastasis foci were concordant with their matched CRC primary tumors. The results support late metastasis and polyclonal seeding. Consequently, we quantitatively compared the intratumor heterogeneity (ITH) between primary and metastasis tumors, and with the help of in silico metastasis simulation, we inferred that more than 10 cells take part in the CRC liver metastasis.

摘要

癌症转移是癌症运动负担的主要原因。对于结直肠癌(CRC),肝脏是最常见的远处转移部位。目前还不太清楚的是,癌症基因组突变是一种细胞内在的、可遗传的特性,在 CRC 肝转移中富集。在这里,我们试图在多克隆播种的背景下回答这个问题。在这项研究中,我们对 18 对结直肠癌原发肿瘤及其匹配的肝转移样本进行了测序。结合公共可用的测序数据,我们比较了 113 对原发和转移样本中的突变。与配对的原发肿瘤相比,转移中 TP53 突变的变异等位基因频率(VAF)显著增加,尽管在肝转移灶中经常观察到的大多数突变与它们匹配的 CRC 原发肿瘤一致。结果支持晚期转移和多克隆播种。因此,我们定量比较了原发肿瘤和转移肿瘤之间的肿瘤内异质性(ITH),并借助计算机模拟转移,我们推断有超过 10 个细胞参与了结直肠癌的肝转移。

相似文献

1
TP53 mutation is enriched in colorectal cancer liver metastasis in the context of polyclonal seeding.TP53 突变在多克隆播种的结直肠癌肝转移中富集。
Pathol Res Pract. 2022 Aug;236:153958. doi: 10.1016/j.prp.2022.153958. Epub 2022 May 27.
2
Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.多区域全外显子组测序匹配的原发和转移肿瘤揭示了结直肠癌转移中的基因组异质性,并提示了多克隆播种。
Ann Oncol. 2017 Sep 1;28(9):2135-2141. doi: 10.1093/annonc/mdx278.
3
Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.肿瘤异质性预示结直肠癌的转移潜能。
Clin Cancer Res. 2017 Dec 1;23(23):7209-7216. doi: 10.1158/1078-0432.CCR-17-0306. Epub 2017 Sep 22.
4
Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing.通过靶向下一代测序对肺或肝转移的结直肠癌患者进行全面的基因突变分析。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231185285. doi: 10.1177/15330338231185285.
5
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.结直肠癌患者原发性肿瘤与配对转移灶的比较分析:基因组和转录谱之间一致性的评估
Eur J Cancer. 2015 May;51(7):791-9. doi: 10.1016/j.ejca.2015.02.012. Epub 2015 Mar 18.
6
Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.原发性和转移性结直肠癌中神经内分泌分化与KRAS/NRAS/BRAF/PIK3CA/TP53突变状态的比较
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5927-39. eCollection 2014.
7
Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.原发性和同步转移性结直肠癌的比较基因组分析。
PLoS One. 2014 Mar 5;9(3):e90459. doi: 10.1371/journal.pone.0090459. eCollection 2014.
8
Genomic and prognostic heterogeneity among RAS/BRAF /TP53 co-mutated resectable colorectal liver metastases.可切除结直肠癌肝转移中 RAS/BRAF/TP53 共突变的基因组和预后异质性。
Mol Oncol. 2021 Apr;15(4):830-845. doi: 10.1002/1878-0261.12885. Epub 2021 Jan 8.
9
P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.结直肠癌肝转移灶的P53突变分析:与实际生存、血管生成状态及P53过表达的关系
Clin Cancer Res. 2005 Jun 1;11(11):4067-73. doi: 10.1158/1078-0432.CCR-04-2389.
10
Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.配对的结直肠癌及其相应肝转移灶中p53突变、微血管密度与新生血管形成的相关性
Int J Oncol. 2002 Aug;21(2):243-9. doi: 10.3892/ijo.21.2.243.

引用本文的文献

1
Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature.通过一个与二硫键凋亡相关的长非编码 RNA 特征预测肝细胞肝癌的预后和化疗药物敏感性。
Sci Rep. 2024 Mar 26;14(1):7157. doi: 10.1038/s41598-024-57954-7.
2
Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG.circSKA3 通过减弱 SLUG 的泛素化和降解来特异性地在细胞内保留,从而促进结直肠癌转移。
Cell Death Dis. 2023 Nov 16;14(11):750. doi: 10.1038/s41419-023-06279-w.
3
Genetic and nongenetic mechanisms for colorectal cancer evolution.
结直肠癌进化的遗传和非遗传机制。
Cancer Sci. 2023 Sep;114(9):3478-3486. doi: 10.1111/cas.15891. Epub 2023 Jun 25.